1. Home
  2. CIVB vs KMDA Comparison

CIVB vs KMDA Comparison

Compare CIVB & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civista Bancshares Inc.

CIVB

Civista Bancshares Inc.

HOLD

Current Price

$23.84

Market Cap

500.4M

Sector

Finance

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.52

Market Cap

458.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIVB
KMDA
Founded
1884
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
500.4M
458.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CIVB
KMDA
Price
$23.84
$8.52
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$26.00
$13.00
AVG Volume (30 Days)
97.6K
76.2K
Earning Date
01-29-2026
03-04-2026
Dividend Yield
3.02%
2.35%
EPS Growth
31.34
30.41
EPS
2.64
0.35
Revenue
$169,173,000.00
$174,787,000.00
Revenue This Year
$15.24
$14.79
Revenue Next Year
$6.52
$11.38
P/E Ratio
$9.03
$23.80
Revenue Growth
13.47
10.36
52 Week Low
$17.47
$5.54
52 Week High
$25.59
$8.88

Technical Indicators

Market Signals
Indicator
CIVB
KMDA
Relative Strength Index (RSI) 52.07 61.67
Support Level $23.35 $7.94
Resistance Level $25.40 $8.71
Average True Range (ATR) 0.82 0.24
MACD -0.06 -0.01
Stochastic Oscillator 43.50 61.09

Price Performance

Historical Comparison
CIVB
KMDA

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: